Emerging nutraceuticals provider Neutra Corp. NTRR -77.46% announced today that it has received the first shipment of two new male enhancement formulas from the manufacturer. Clinical trials of the supplements are now underway.

The testing is part of NTRR's strategy to produce a safe and effective alternative to prescription male enhancers such as Viagra. The company plans to market a product with no side effects, and clinical trials will be crucial to the process of fine-tuning the new formulas.

"We want to deliver a male enhancement supplement with the best chance of success that we possibly can," said NTRR CEO Michael-Shane Henderson. "We'll be monitoring our test group carefully and listening closely in order to craft an all-natural product that both men and women will love. The market for sexual health products is booming around the world, and NTRR will soon be positioned to capitalize on that growth."

Neutra Corp. is developing innovative, all-natural products to compete in the fast-growing nutraceuticals industry alongside Herbalife Ltd. HLF +3.40% , Vitamin Shoppe VSI +2.81% , Nutraceutical International Corp. NUTR +1.61% and Schiff Nutrition International Inc. .

For more information on NTRR's nutraceuticals initiative, please visit www.neutracorp.com/investors .

Follow NTRR on Twitter at www.twitter.com/neutracorp .

About Neutra Corp.

Neutra Corp. ( www.neutracorp.com ) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors .

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

SOURCE: Neutra Corp.